{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T01:15:27Z","timestamp":1787620527442,"version":"build-2736575974"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T00:00:00Z","timestamp":1705536000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.ejmech.2024.116162","type":"journal-article","created":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T18:24:07Z","timestamp":1705602247000},"page":"116162","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Novel aroyl guanidine anti-trypanosomal compounds that exert opposing effects on parasite energy metabolism"],"prefix":"10.1016","volume":"268","author":[{"given":"Swapna","family":"Varghese","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anubhav","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6569-8241","authenticated-orcid":false,"given":"Siu Wai","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thuy","family":"Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noel","family":"Pitcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathilda","family":"Mesnard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Lallemand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raphael","family":"Rahmani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah R.","family":"Moawad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiantong","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brad E.","family":"Sleebs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P.","family":"Barrett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa L.","family":"Sykes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicky M.","family":"Avery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darren J.","family":"Creek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan B.","family":"Baell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2024.116162_bib1","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/1476-072X-9-57","article-title":"The Atlas of human African trypanosomiasis: a contribution to global mapping of neglected tropical diseases","volume":"9","author":"Simarro","year":"2010","journal-title":"Int. J. Health Geogr."},{"key":"10.1016\/j.ejmech.2024.116162_bib2","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1179\/2047773213Y.0000000105","article-title":"A current analysis of chemotherapy strategies for the treatment of human African trypanosomiasis","volume":"107","author":"Babokhov","year":"2013","journal-title":"Pathog. Glob. Health"},{"key":"10.1016\/j.ejmech.2024.116162_bib3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005585","article-title":"Monitoring the elimination of human African trypanosomiasis: update to 2014","volume":"11","author":"Franco","year":"2017","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.ejmech.2024.116162_bib4","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1476-072X-13-4","article-title":"Mapping the capacities of fixed health facilities to cover people at risk of gambiense human African trypanosomiasis","volume":"13","author":"Simarro","year":"2014","journal-title":"Int. J. Health Geogr."},{"key":"10.1016\/j.ejmech.2024.116162_bib5","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0031-6997(25)00445-4","article-title":"Recent research on the biological activity of suramin","volume":"45","author":"Voogd","year":"1993","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejmech.2024.116162_bib6","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s00436-002-0799-9","article-title":"Arsenicals (melarsoprol), pentamidine and suramin in the treatment of human African trypanosomiasis","volume":"90","author":"Nok","year":"2003","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.ejmech.2024.116162_bib7","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.pt.2018.04.002","article-title":"Melarsoprol resistance in African trypanosomiasis","volume":"34","author":"Fairlamb","year":"2018","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.ejmech.2024.116162_bib8","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.pt.2012.12.005","article-title":"Drug resistance in African trypanosomiasis: the melarsoprol and pentamidine story","volume":"29","author":"Baker","year":"2013","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.ejmech.2024.116162_bib9","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0140-6736(09)61117-X","article-title":"Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised, phase III, non-inferiority trial","volume":"374","author":"Priotto","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2024.116162_bib10","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s40265-019-1051-6","article-title":"Fexinidazole: first global approval","volume":"79","author":"Deeks","year":"2019","journal-title":"Drugs"},{"key":"10.1016\/j.ejmech.2024.116162_bib11","doi-asserted-by":"crossref","first-page":"e1151","DOI":"10.1371\/journal.pntd.0001151","article-title":"SCYX-7158, an orally-active benzoxaborole for the treatment of stage 2 human African trypanosomiasis","volume":"5","author":"Jacobs","year":"2011","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.ejmech.2024.116162_bib12","doi-asserted-by":"crossref","first-page":"665","DOI":"10.4269\/ajtmh.2009.09-0015","article-title":"Development of an Alamar Blue viability assay in 384-well format for high throughput whole cell screening of Trypanosoma brucei brucei bloodstream form strain 427","volume":"81","author":"Sykes","year":"2009","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.ejmech.2024.116162_bib13","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1021\/ci300461a","article-title":"Broad coverage of commercially available lead-like screening space with fewer than 350,000 compounds","volume":"53","author":"Baell","year":"2013","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.ejmech.2024.116162_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0001896","article-title":"Identification of compounds with anti-proliferative activity against trypanosoma brucei brucei strain 427 by a whole cell viability based HTS campaign","volume":"6","author":"Sykes","year":"2012","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.ejmech.2024.116162_bib15","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.ejmech.2013.05.007","article-title":"3-(Oxazolo[4,5-b]pyridin-2-yl)anilides as a novel class of potent inhibitors for the kinetoplastid Trypanosoma brucei, the causative agent for human African trypanosomiasis","volume":"66","author":"Ferrins","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116162_bib16","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1021\/ml400487t","article-title":"Facile synthesis and preliminary structure-activity analysis of new sulfonamides against trypanosoma brucei","volume":"5","author":"Rashad","year":"2014","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2024.116162_bib17","doi-asserted-by":"crossref","first-page":"6393","DOI":"10.1021\/jm500191u","article-title":"Pyridyl benzamides as a novel class of potent inhibitors for the kinetoplastid Trypanosoma brucei","volume":"57","author":"Ferrins","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116162_bib18","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1039\/C4MD00406J","article-title":"Synthesis and evaluation of phenoxymethylbenzamide analogues as anti-trypanosomal agents","volume":"6","author":"Manos-Turvey","year":"2015","journal-title":"MedChemComm"},{"key":"10.1016\/j.ejmech.2024.116162_bib19","doi-asserted-by":"crossref","first-page":"6753","DOI":"10.1021\/acs.jmedchem.5b00438","article-title":"6-Arylpyrazine-2-carboxamides: a new core for trypanosoma brucei inhibitors","volume":"58","author":"Rahmani","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116162_bib20","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/s11306-016-1062-1","article-title":"Metabolomics and lipidomics reveal perturbation of sphingolipid metabolism by a novel anti-trypanosomal 3-(oxazolo[4,5-b]pyridine-2-yl)anilide","volume":"12","author":"Stoessel","year":"2016","journal-title":"Metabolomics"},{"key":"10.1016\/j.ejmech.2024.116162_bib21","first-page":"28","article-title":"\u03b1-Phenylthiourea","author":"Frank","year":"1948","journal-title":"Org. Synth."},{"key":"10.1016\/j.ejmech.2024.116162_bib22","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.chembiol.2021.01.021","article-title":"Nuisance compounds in cellular assays","volume":"28","author":"Dahlin","year":"2021","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.ejmech.2024.116162_bib23","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1126\/science.abi4708","article-title":"Drug-induced phospholipidosis confounds drug repurposing for SARS-CoV-2","volume":"373","author":"Tummino","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2024.116162_bib24","doi-asserted-by":"crossref","first-page":"e1618","DOI":"10.1371\/journal.pntd.0001618","article-title":"Untargeted metabolomics reveals a lack of synergy between nifurtimox and eflornithine against Trypanosoma brucei","volume":"6","author":"Vincent","year":"2012","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.ejmech.2024.116162_bib25","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0248-4900(88)90075-5","article-title":"Compartmentation of glycolysis in trypanosomes: a potential target for new trypanocidal drugs","volume":"64","author":"Michels","year":"1988","journal-title":"Biol. Cell."},{"key":"10.1016\/j.ejmech.2024.116162_bib26","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1073\/pnas.030539197","article-title":"Compartmentation protects trypanosomes from the dangerous design of glycolysis","volume":"97","author":"Bakker","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejmech.2024.116162_bib27","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/0305-0491(84)90104-4","article-title":"Pyruvate kinase: a carnitine-regulated site of ATP production in Trypanosoma brucei brucei","volume":"78","author":"Gilbert","year":"1984","journal-title":"Comp. Biochem. Physiol. B"},{"key":"10.1016\/j.ejmech.2024.116162_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005552","article-title":"Trypanosoma brucei TbIF1 inhibits the essential F1-ATPase in the infectious form of the parasite","volume":"11","author":"Panicucci","year":"2017","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.ejmech.2024.116162_bib29","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1038\/ncomms3865","article-title":"Essential regulation of cell bioenergetics in Trypanosoma brucei by the mitochondrial calcium uniporter","volume":"4","author":"Huang","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2024.116162_bib30","article-title":"How much (ATP) does it cost to build a trypanosome? A theoretical study on the quantity of ATP needed to maintain and duplicate a bloodstream-form Trypanosoma brucei cell","volume":"19","author":"Nascimento","year":"2023","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ejmech.2024.116162_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006450","article-title":"Benzoxaborole treatment perturbs S-adenosyl-L-methionine metabolism in Trypanosoma brucei","volume":"12","author":"Steketee","year":"2018","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.ejmech.2024.116162_bib32","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1124\/mol.114.096016","article-title":"Potent trypanocidal curcumin analogs bearing a monoenone linker motif act on trypanosoma brucei by forming an adduct with trypanothione","volume":"87","author":"Alkhaldi","year":"2015","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejmech.2024.116162_bib33","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1128\/AAC.00044-13","article-title":"Metabolomics guides rational development of a simplified cell culture medium for drug screening against Trypanosoma brucei","volume":"57","author":"Creek","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2024.116162_bib34","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1124\/mol.112.082321","article-title":"Pyrimidine salvage in Trypanosoma brucei bloodstream forms and the trypanocidal action of halogenated pyrimidines","volume":"83","author":"Ali","year":"2013","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejmech.2024.116162_bib35","doi-asserted-by":"crossref","first-page":"985","DOI":"10.2307\/3282883","article-title":"Continuous cultivation of Trypanosoma brucei blood stream forms in a medium containing a low concentration of serum protein without feeder cell layers","volume":"75","author":"Hirumi","year":"1989","journal-title":"J. Parasitol."},{"key":"10.1016\/j.ejmech.2024.116162_bib36","doi-asserted-by":"crossref","first-page":"8703","DOI":"10.1021\/ac2021823","article-title":"Toward global metabolomics analysis with hydrophilic interaction liquid chromatography-mass spectrometry: improved metabolite identification by retention time prediction","volume":"83","author":"Creek","year":"2011","journal-title":"Anal. Chem."},{"key":"10.1016\/j.ejmech.2024.116162_bib37","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1093\/bioinformatics\/bts069","article-title":"IDEOM: an Excel interface for analysis of LC-MS-based metabolomics data","volume":"28","author":"Creek","year":"2012","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ejmech.2024.116162_bib38","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/978-1-0716-0239-3_21","article-title":"Using the IDEOM workflow for LCMS-based metabolomics studies of drug mechanisms","volume":"2104","author":"Srivastava","year":"2020","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.ejmech.2024.116162_bib39","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1038\/nbt.2377","article-title":"A cross-platform toolkit for mass spectrometry and proteomics","volume":"30","author":"Chambers","year":"2012","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ejmech.2024.116162_bib40","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1186\/1471-2105-9-504","article-title":"Highly sensitive feature detection for high resolution LC\/MS","volume":"9","author":"Tautenhahn","year":"2008","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.ejmech.2024.116162_bib41","doi-asserted-by":"crossref","first-page":"2786","DOI":"10.1021\/ac2000994","article-title":"PeakML\/mzMatch: a file format, Java library, R library, and tool-chain for mass spectrometry data analysis","volume":"83","author":"Scheltema","year":"2011","journal-title":"Anal. Chem."},{"key":"10.1016\/j.ejmech.2024.116162_bib42","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/nbt0807-846b","article-title":"The metabolomics standards initiative","volume":"25","author":"Sansone","year":"2007","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ejmech.2024.116162_bib43","doi-asserted-by":"crossref","first-page":"D354","DOI":"10.1093\/nar\/gkj102","article-title":"From genomics to chemical genomics: new developments in KEGG","volume":"34","author":"Kanehisa","year":"2006","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejmech.2024.116162_bib44","doi-asserted-by":"crossref","first-page":"W606","DOI":"10.1093\/nar\/gkm324","article-title":"LIPID MAPS online tools for lipid research","volume":"35","author":"Fahy","year":"2007","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejmech.2024.116162_bib45","series-title":"MetaboAnalyst 4.0: towards More Transparent and Integrative Metabolomics Analysis","author":"Chong","year":"2018"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523424000424?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523424000424?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T15:05:18Z","timestamp":1759331118000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523424000424"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":45,"alternative-id":["S0223523424000424"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.116162","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel aroyl guanidine anti-trypanosomal compounds that exert opposing effects on parasite energy metabolism","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.116162","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"116162"}}